ENANTA PHARMACEUTICALS INC Quarterly Return On Assets in % from Q4 2013 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Enanta Pharmaceuticals Inc quarterly/annual Return On Assets history and growth rate from Q4 2013 to Q2 2024.
  • Enanta Pharmaceuticals Inc Return On Assets for the quarter ending June 30, 2024 was -27.1 %, a 20.8% increase year-over-year.
  • Enanta Pharmaceuticals Inc annual Return On Assets for 2023 was -32.8 %, a 8.32% decline from 2022.
  • Enanta Pharmaceuticals Inc annual Return On Assets for 2022 was -30.3 %, a 76.1% decline from 2021.
  • Enanta Pharmaceuticals Inc annual Return On Assets for 2021 was -17.2 %, a 140% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -27.1 +7.11 +20.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -29.3 +5.48 +15.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -32.3 -0.44 -1.38% Oct 1, 2023 Dec 31, 2023
Q3 2023 -32.8 -2.52 -8.32% Jul 1, 2023 Sep 30, 2023
Q2 2023 -34.2 -5.48 -19.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -34.8 -8.89 -34.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -31.9 -9.42 -42% Oct 1, 2022 Dec 31, 2022
Q3 2022 -30.3 -13.1 -76.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -28.7 -11 -61.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -25.9 -10.7 -70.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -22.4 -10.8 -92.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -17.2 -10 -140% Jul 1, 2021 Sep 30, 2021
Q2 2021 -17.8 -18.2 -3906% Apr 1, 2021 Jun 30, 2021
Q1 2021 -15.2 -20 -419% Jan 1, 2021 Mar 31, 2021
Q4 2020 -11.6 -18.6 -266% Oct 1, 2020 Dec 31, 2020
Q3 2020 -7.15 -17 -172% Jul 1, 2020 Sep 30, 2020
Q2 2020 0.47 -13.9 -96.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 4.76 -13.5 -73.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 6.99 -14.6 -67.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 9.87 -9.46 -48.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 14.3 -8.81 -38.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 18.2 +2.1 +13% Jan 1, 2019 Mar 31, 2019
Q4 2018 21.5 +10.3 +91.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 19.3 +13.2 +217% Jul 1, 2018 Sep 30, 2018
Q2 2018 23.1 +30.5 Apr 1, 2018 Jun 30, 2018
Q1 2018 16.1 +20.9 Jan 1, 2018 Mar 31, 2018
Q4 2017 11.3 +14.6 Oct 1, 2017 Dec 31, 2017
Q3 2017 6.11 -1.61 -20.9% Jul 1, 2017 Sep 30, 2017
Q2 2017 -7.39 -18.2 -169% Apr 1, 2017 Jun 30, 2017
Q1 2017 -4.73 -17.3 -138% Jan 1, 2017 Mar 31, 2017
Q4 2016 -3.38 -28.5 -113% Oct 1, 2016 Dec 31, 2016
Q3 2016 7.72 -25.7 -76.9% Jul 1, 2016 Sep 30, 2016
Q2 2016 10.8 -21.1 -66.2% Apr 1, 2016 Jun 30, 2016
Q1 2016 12.6 -47.1 -79% Jan 1, 2016 Mar 31, 2016
Q4 2015 25.1 -26.2 -51.1% Oct 1, 2015 Dec 31, 2015
Q3 2015 33.4 +7.61 +29.5% Jul 1, 2015 Sep 30, 2015
Q2 2015 31.9 +3.58 +12.6% Apr 1, 2015 Jun 30, 2015
Q1 2015 59.7 +76.5 Jan 1, 2015 Mar 31, 2015
Q4 2014 51.2 +66.2 Oct 1, 2014 Dec 31, 2014
Q3 2014 25.8 Jul 1, 2014 Sep 30, 2014
Q2 2014 28.3 Apr 1, 2014 Jun 30, 2014
Q1 2014 -16.8 Jan 1, 2014 Mar 31, 2014
Q4 2013 -15 Oct 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.